EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacist-Driven Inpatient to Clinic Transitions of Care Pilot in Patients with Acute Ischemic Stroke

Kerri Jones, Shaheer Arif, Kiran Nagarajan, Vamsi Gorijala, Mohamed Elnaeim, Drew A. Wells

Stroke Clinician · 19.03.2026

DOI: 10.59236/sc.v3i1.110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke Clinician, online erschienen am 19.03.2026. Verfasst von Kerri Jones und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Effective post-discharge care is critical for optimizing outcomes and preventing recurrent events after acute ischemic stroke (AIS). This study evaluates the impact of a pharmacist-driven transition of care process on stroke clinic follow-up rates.

Methods

We conducted a single-center, retrospective pilot study of patients aged ≥18 years discharged with AIS between January 1 and December 31, 2024. Patients with hemorrhagic stroke, no confirmed AIS on imaging, death, or discharge to institutional care were excluded. Enrolled patients received a follow-up call from a pharmacist within 21 days of discharge, providing stroke education and emphasizing the importance of clinic follow-up. Our control group did not receive follow-up calls. The primary outcome was clinic follow-up rate; secondary outcomes included time to follow-up, 30- and 90-day hospital readmissions, and 30-day ED visits.

Results

Of 117 patients, 80 (68%) received pharmacist calls, and 37 (32%) were controls. Baseline characteristics were similar between groups (predominantly African American, with common comorbidities including hypertension and hyperlipidemia). Stroke etiology was most commonly cryptogenic, followed by cardioembolic, large artery atherosclerosis, and small vessel disease. Follow-up rates were 29% in the intervention group vs 21% in controls (p=0.42). Median time to follow-up was shorter in the intervention group (119 vs 153 days, p=0.2), though not statistically significant. Overall, 74% of patients who followed up to the clinic received a pharmacist call. No statistically significant differences were observed in 30- or 90-day readmission rates between the two groups.

Conclusion

A pharmacist-led transition of care intervention showed improvement that was not statistically significant in clinic follow-up rate and median time to follow-up after AIS. However, it provided meaningful insight into the potential of this process. Further studies are needed to evaluate the role in improving patient outcomes.

Zitieren

APA

Jones, K., Arif, S., Nagarajan, K., Gorijala, V., Elnaeim, M., & Wells, D. A. (2026). Pharmacist-Driven Inpatient to Clinic Transitions of Care Pilot in Patients with Acute Ischemic Stroke. Stroke Clinician. https://doi.org/10.59236/sc.v3i1.110

Vancouver

Jones K, Arif S, Nagarajan K, Gorijala V, Elnaeim M, Wells DA. Pharmacist-Driven Inpatient to Clinic Transitions of Care Pilot in Patients with Acute Ischemic Stroke. Stroke Clinician. 2026. doi:10.59236/sc.v3i1.110

BibTeX
@article{Jones2026,
  author = {Jones, Kerri and Arif, Shaheer and Nagarajan, Kiran and Gorijala, Vamsi and Elnaeim, Mohamed and Wells, Drew A.},
  title = {Pharmacist-Driven Inpatient to Clinic Transitions of Care Pilot in Patients with Acute Ischemic Stroke},
  journal = {Stroke Clinician},
  year = {2026},
  doi = {10.59236/sc.v3i1.110}
}
Kostenlos starten →